McKesson to Administer Cephalon Programs for Cancer Pain

Cephalon, a Woodlands, Texas, medical device company, has chosen McKesson Specialty Health to administer its FDA-approved FENTORA and ACIQ Risk Evaluation and Mitigation Strategy Programs for management breakthrough pain in cancer patients, according to a McKesson news release.

Advertisement

McKesson Specialty Health will now administer Cephalon REMS programs and McKesson’s sister organization RelayHealth will allow patients to have their prescriptions filled at any local retail pharmacy enrolled in the ACTIQ and FENTORA REMS programs.

Related Articles on McKesson:

CMS Chooses McKesson’s InterQual Criteria for Medicare Inpatient Services Audit Program

McKesson Partners With Lakewood health System in Minnesota

Fraud, Waste and Abuse Tools Integrate to McKesson Total Payment

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.